SOPRANO: Macitentan in patients with pulmonary hypertension following left ventricular assist device implantation.

Autor: Frantz RP; Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota United States of America., Desai SS; Inova Fairfax Medical Center Falls Church Virginia United States of America., Ewald G; Washington University St. Louis Missouri United States of America., Franco V; Ohio State University Columbus Ohio United States of America., Hage A; Cedars-Sinai Medical Center Los Angeles California United States of America., Horn EM; Weill Cornell Medical College New York New York United States of America., LaRue SJ; Hannibal Clinic Hannibal Missouri United States of America., Mathier MA; University of Pittsburgh Pittsburgh Pennsylvania United States of America., Mandras S; AdventHealth Orlando Florida United States of America., Park MH; Virginia Mason Franciscan Health Tacoma Washington United States of America., Ravichandran AK; Ascension Medical Group Indianapolis Indiana United States of America., Schilling JD; Washington University St. Louis Missouri United States of America., Wang IW; Memorial Healthcare System Hollywood Florida United States of America., Zolty R; University of Nebraska Medical Center Omaha Nebraska United States of America., Rendon GG; Actelion Pharmaceuticals US, Inc. Titusville New Jersey United States of America., Rocco MA; Actelion Pharmaceuticals US, Inc. Titusville New Jersey United States of America., Selej M; Actelion Pharmaceuticals US, Inc. Titusville New Jersey United States of America., Zhao C; Actelion Pharmaceuticals US, Inc. Titusville New Jersey United States of America., Rame JE; Thomas Jefferson University Hospital Philadelphia Pennsylvania United States of America.

Publikováno v: Pulmonary circulation [Pulm Circ] 2024 Dec 04; Vol. 14 (4), pp. e12446. Date of Electronic Publication: 2024 Dec 04 (Print Publication: 2024).